New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease Presented at the 2025 Alzheimer’s Association International Conference featuring Veravas Inc.
/
DateJul 28 2025
Developed by Veravas Inc., VeraBIND™ Tau Assay is the first blood-based test that measures pathologically active tau for the early detection of Alzheimer’s disease in... Read More →